Le Lézard
Classified in: Health
Subject: DIS

Ever Learning's All Access Autism Toolkit helps Parents of Children with Autism


MENLO PARK, Calif., March 13, 2020 /PRNewswire-PRWeb/ -- SCARCITY OF TRAINED PROFESSIONALS TO IMPLEMENT EVIDENCE-BASED INTERVENTION PROGRAMS FOR AUTISM

There are approximately 700,000 people with autism in the world, using a conservative rate of 1 in 100. Less than 10% of the world's population with autism have access to a life-changing intervention known as Applied Behavioral Analysis. ABA is an evidenced-based intervention that has demonstrated with early and intensive application to generate success helping children with autism to mainstream. Furthermore, ABA can help over 90% of people on the autism spectrum achieve some level of independence. Currently, we are experiencing a shortage of Board Certified Behavioral Analysts (BCBAs), certified ABA experts, with only 29,000 worldwide (and most within the U.S.). As a result of the scarcity of ABA experts to treat and supervise intervention programs, ABA therapy is currently only accessible in a handful of countries and many in families are on a waitlist for services.

The universal challenge then is twofold: 1) ABA programs consume a significant amount of time and resources (about 35 hours per week. 2) Correspondingly, ABA is very expensive with costs ranging from $75,000 ?- $125,000 annually. Even if a portion of ABA therapy is covered by insurance, the out-of-pocket costs are still substantial.

MAKING ABA INTERVENTION PROGRAMS MORE ACCESSIBLE, AFFORDABLE, AND EASIER TO CUSTOMIZE FOR PARENTS, EDUCATORS AND CLINICIANS

Ever Learning's All Access Autism Toolkit is a monthly Subscription that delivers Autism training and Problem Behavior videos, Social Stories, Flashcards, Visual Schedules, File Folders, Tracing Cards, Assessment Tools, Data Sheets, Literature Summaries, Educator Training Series ? and hundreds of other products easily accessible for an affordable price of $9.99/month to anyone with an internet connection anywhere in the world!

"With Ever Learning's All-Access, parents, educators and even clinicians have access to hundreds of customizable tools to tailor ABA interventions programs for their own specific needs." said Karen Chung, CEO at Special Learning, Inc.

For more information on Ever Learning and the All-Access Autism Toolkit, visit http://www.ever-learning.com.

ABOUT EVER LEARNING

Ever Learning provides the global autism community with highest quality training, education and teaching resources to support the learning needs of children, adolescents and adults with Autism and other special needs.

Ever Learning is a sister company of Special Learning, Inc., a company founded by an entrepreneur with a mission to help families, educators and professionals living with autism acquire the skills they need to live happy, fulfilling lives.

 

SOURCE Ever Learning


These press releases may also interest you

at 10:46
FullCare Medical has launched a new medical garment production facility in Tatu City, the 5,000-acre mixed-use Special Economic Zone (SEZ) in Kenya....

at 10:45
Moleculin Biotech, Inc., (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today announced Walter Klemp, President and Chief Executive Officer of...

at 10:38
Neurent Medical, a company pioneering innovative non-surgical interventions to treat chronic inflammatory sinonasal diseases, today announced the appointment of Mr. John Peterson as the new Vice President of Sales & Marketing, effective immediately....

at 10:30
Endoscopy Equipment Market in terms of revenue was estimated to be worth $32.3 billion in 2024 and is poised to reach $46.2 billion by 2029, growing at a CAGR of 7.4% from 2024 to 2029 according to a new report by MarketsandMarketstm. The growth in...

at 10:29
Integrity Marketing Group, LLC ("Integrity"), one of the leading independent distributors of life, health and wealth products, today announced that Integrity Co-Founder and CEO Bryan W. Adams has been recognized as a top CEO for large companies in...

at 10:28
On March 28, 2024, Broncus Medical (02216.HK) (the "Company" or "we" ) announced annual results for FY 2023. In 2023, Broncus Medical earned product sales of US$12.41 million, an increase of 32% compared to the previous year. Of which, total revenue...



News published on and distributed by: